Plerixafor 24mg/1.2mL Injection

Plerixafor 24mg is a stem-cell mobilisation medicine used with G-CSF before collection of a patient’s own blood stem cells for transplantation in selected myeloma or lymphoma settings.
The clinical team gives a subcutaneous injection timed before apheresis, commonly about 11 hours before collection. Body weight and kidney function determine the regimen. G-CSF forms part of the mobilisation course.
Plerixafor blocks CXCR4 signalling, disrupting retention of stem cells in the marrow and allowing more to enter circulating blood.
Diarrhoea, nausea, injection-site reactions, headache and dizziness can occur. Severe abdominal or left shoulder pain, allergic symptoms or fainting needs prompt assessment.
Blood counts and circulating CD34-positive cells guide collection. Splenic enlargement or rupture is a rare concern. Mobilisation in leukaemia can release malignant cells and is not its usual role.
Increasing circulating stem cells can improve the chance of collecting a sufficient transplant graft.
No. It helps move stem cells into the blood so that they can be collected and stored for a later transplant.
The rise in circulating stem cells follows a predictable time course, which the apheresis schedule uses.
It is generally used together with G-CSF rather than as an assumed substitute.
Circulating CD34-positive cells help estimate whether enough stem cells are available for apheresis.
Apheresis: separation and collection of selected blood components. CD34: a marker used to identify blood stem cells. Autologous transplant: transplantation using the patient’s own cells.; AR: Plerixafor 24mg حقن; FR: Plerixafor 24mg injection; PT: Plerixafor 24mg injeção; ES: Plerixafor 24mg inyección; RU: Plerixafor 24mg инъекция; ID: Plerixafor 24mg suntikan; VI: Plerixafor 24mg thuốc tiêm; MS: Plerixafor 24mg suntikan; TL: Plerixafor 24mg iniksyon; ZH-SG: Plerixafor 24mg 注射剂
International B2B Enquiry
Send a structured B2B enquiry for Plerixafor 24mg/1.2mL Injection under Blood Care. Global Medicines Export helps international buyers review product information, pack details, quantity requirements, destination-market needs, quotation support and export documentation coordination from India.
Product name, required strength or pack, expected quantity, destination country, buyer type and preferred manufacturer if any.
Availability, quotation support, documentation expectations and shipment-ready order communication can be reviewed before confirmation.
Commercial invoice, packing information, manufacturer details, batch details and supporting documents where applicable and available.
Product availability, quotation, and documentation support are coordinated for international B2B enquiries.
Plerixafor 24mg/1.2mL Injection